Development and evaluation of a rapid and reliable method for cytochrome P450 2C8 genotyping

Clinical Laboratory

Volumn 50, Issue 3-4, 2004, Pages 141-148

  Weise, A ^a   Grundler, S ^a   Zaumsegel, D ^b   Klotzek, M ^b   Grondahl B ^a   Forst, T ^a   Pfützner, Andreas ^a,b  

^a IKFE GmbH   (Germany)

^b UNIVERSITY OF APPLIED SCIENCES   (Germany)

Author keywords

CYP2C8; Pharmacogenetics; Real time PCR

Indexed keywords

CYTOCHROME P450 2C8; DNA; ISOENZYME;

ADULT; AGED; ALLELE; ARTICLE; CAUCASIAN; CLINICAL LABORATORY; CLINICAL PROTOCOL; CLINICAL RESEARCH; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEVICE; DNA POLYMORPHISM; DRUG METABOLISM; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; HYBRIDIZATION; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR PROBE; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TIME;

ARYL HYDROCARBON HYDROXYLASES; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; FEMALE; FLUORESCENCE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REPRODUCIBILITY OF RESULTS;

EID: 1842636202     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Linder MW, Valdes R. Pharmacogenetics in the practice of laboratory medicine. Mol Diag 1999a; 4:365-379
2. Linder MW, Valdez R. Fundamentals and applications of pharmacogenetics for the clinical laboratory. Ann Clin Lab Sci 1999b; 29:140-149
3. Nelson DR, Kamataki T, Waxman DJ et al. The P450 super-family: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes and nomenclature. DNA Cell Biol 1993; 12:1-51
4. Otterness D, Szumlanski C, Lennard L et al. Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms. Clin Pharmacol Ther 1997; 62:60-73
5. Chen S, Chou WH, Blouin RA et al. The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: Screening costs and influence in clinical outcomes in psychiatry. Clin Pharmacol Ther 1996; 60:522-534
6. Masimirembwa C, Bertilsson L, Johnansson I, Hasler JA, Ingelman-Sundberg M. Phenotyping and genotyping of S-mephenytoin hydroxylase (cytochrome P450 2C19) in a Shona population of Zimbabwe. Clin Pharmacol Ther 1995; 57:656-661
7. Stubbins MJ, Harris LW, Smith G, Tarbit MH, Wolf CR. Genetic analysis of the human cytochrome P450 CYP2C9 locus. Pharmacogenetics 1997; 7:59-64
8. Goldstein JA. Clinical relevance of genetic polymorphisms in human CYP2C subfamily. Br J Clin Pharmacol 2001; 52:349-355
9. Daly AK. Pharmacogenetics of the major polymorphic metabolizing enzymes. Fundam Clin Pharmacol 2003; 17:27-41.
10. Bahadur N, Leathart JB, Mutch E, et al. CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6alpha-hydroxylase activity in human liver microsomes. Biochem Pharmacol. 2002; 64:1579-89
11. Soyama A, Saito Y, Hanioka et al. Non-synonymous single nucleotide alterations found in the CYP2C8 gene result in reduced in vitro paclitaxel metabolism. Biol Pharm Bull 2001; 24:1427-1430
12. Dai D, Zeldin DC, Blaisdell JA, Chanas B, Coulter SJ, Ghanayem BI, Goldstein JA. Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid. Pharmacogenetics 2001; 11:597-607
13. Yasar U, Lundgren S, Eliasson E et al. Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms. Biochem Biophys Res Commun 2002, 299:25-28
14. Kimura S, Pastewka J, Gelboin HV, Gonzalez FJ, CDNA and amino acid sequence of 2 members of the human P450iic gene subfamily. Nucleic Acids Res 1987; 15:10053-10054